Long-acting insulins set to dominate diabetes therapeutics market to 2014

Oct. 26, 2011 - PRLog -- According to the report “European Diabetes Therapeutics Market” available at http://www.pharmaceutical-market-research.com/publications/therapeutic/european_diabetes_therapeutics_market.html
the launch of new classes of oral antidiabetic drugs by 2014 will uplift prospects for the European diabetes therapeutics market.

The 151 page report states that long-acting insulins are set to grab a large share of the market in the future. The alarming growth rate of diabetes and its strong growth over the last year has encouraged market participants in the pharmaceuticals industry to venture into the rapidly increasing diabetics therapeutics segment. With an abundance of successful formulations in the pipeline, competition in the market will be turned up a few notches. The insulin market is dominated by modern insulins and analogues. Long-acting insulins are expected to have a large market in the future. New therapeutic classes of drugs are expected to be a major contributor to the OAD segment.

The expense for diabetes treatment has become a global burden, especially for the middle- and low-income groups. Participants in this space are battling pricing pressures; however, high levels of competition, improved therapies, and the introduction of biosimilars will help deal with this issue. Major concerns surrounding drug safety and side effects have created cause for concern among participants. This factor will have an impact on the global market in the near future, considering the need for compliance with strict European Medicines Agency and Food and Drug Administration (FDA) guidelines. These issues have alarmed medicines agencies to have strict control over efficacy and safety data. As new types of products emerge in the market, safety issues are bound to have a high impact in the future.

The report “European Diabetes Therapeutics Market” is available from Piribo at:
http://www.pharmaceutical-market-research.com/publication...

Piribo product ID: FRS02545

About Piribo

Piribo http://www.pharmaceutical-market-research.com/publications/therapeutic/european_diabetes_therapeutics_market.html is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.